Investing

Rebecca Teltscher says AtkinsRéalis’ nuclear growth highlights the appeal of hard-asset investing amid AI disruption concerns.

Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.

Stock markets continue to hit new highs despite a troubling economic climate at home and abroad.   

In the latest episode of Ticker Take, I spoke with Jay Hatfield, CEO of Infrastructure Capital Advisors, about a strategy designed to do exactly that.

The Carney government is putting a new emphasis on diplomacy with Persian Gulf countries — one that goes beyond seeking investments in Canada to arrangements touching on defence and artificial intelligence.

Saskatchewan and B.C. credit unions rebounded in 2025 as lower funding costs and improving margins boosted earnings.

Cannabis stocks may benefit from U.S. rescheduling and European growth as medical cannabis markets expand globally.

Don Drummond says slower immigration is driving weaker job and GDP growth in Canada, not broader economic weakness.

Dow retakes 50,000 as AI-driven optimism boosts tech stocks, Cisco rallies and investors monitor U.S.-China trade talks.

Birchcliff Energy raised 2026 cash flow guidance after reporting stronger first-quarter profit and diversified gas market exposure.

Strong U.S. retail sales are adding to inflation concerns and raising expectations for higher Treasury yields and steady interest rates.

Markets are pricing in an eventual end to the Iran conflict as strong earnings and AI optimism push stocks higher, says Ryan Belanger.

Survey finds many Canadian kids understand money concepts, but parents say fewer are prepared to manage finances independently.

Biotech stocks tied to cancer, autoimmune and rare disease therapies gain attention as M&A activity boosts sector sentiment.

Chris Kerlow discusses active investing, gold equities, AI disruption and why he is cautious on Alphabet and Meta amid market volatility.